Therapix Biosciences (TRPXD) Stock Price, News & Analysis

Company Overview

Therapix Biosciences Ltd. was an Israel-based clinical-stage biotechnology company focused on developing cannabinoid-based therapies for medical conditions with limited treatment options. The company’s research centered on pharmaceutical formulations designed to target neurological, sleep-related and pain-related disorders.

Its development pipeline historically included THX-OSA, an investigational therapy for obstructive sleep apnea, and THX-ULD, an investigational treatment for Tourette syndrome. These programs were based on combinations or formulations of cannabinoid-related compounds intended to support therapeutic applications beyond the recreational use of cannabis.

Therapix Biosciences conducted research and development activities through clinical programs and collaborations, primarily serving the international pharmaceutical and biotechnology markets. Publicly available information about the company’s current operations, leadership and commercial activities is limited.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 900 shs
• Average Volume: 1,852 shs
• Market Capitalization: $299 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:TRPXD
• CIK: N/A
• Web: therapixbio.com
• Phone: 972 3 616 7055
• Fax: N/A
• Employees: 8
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.49
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.28 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 50,000
• Free Float: N/A
• Market Cap: $299 thousand
• Optionable: Not Optionable
• Beta: N/A